Harrow SG&A Expense (Semi Annual) Insights

Harrow, Inc. (HROW)

35.74 +0.43 (+1.22%) USD | NASDAQ | Apr 06, 12:30

View SG&A Expense (Semi Annual) for HROW.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (Semi Annual) Chart

Start Trial

View Historical Data

Start Trial

View SG&A Expense (Semi Annual) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View SG&A Expense (Semi Annual) Benchmarks

Start Trial

Esperion Therapeutics, Inc.	--
Corcept Therapeutics, Inc.	--
Regeneron Pharmaceuticals, Inc.	--
Theravance Biopharma, Inc.	--
Rhythm Pharmaceuticals, Inc.	--